aTyr Pharma | LIFE - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Ardelyx USD 102.27M 26.35M 2026-03
aTyr Pharma USD 700.63K 81.56M 2026-03
Biogen USD 709.7M 155.4M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.43M 222K 2026-03
CSL USD 1.23B 498M 2025-12
Curis USD 1.34M 3.45M 2025-12
GlaxoSmithKline GBP 2.19B 75M 2026-06
Grifols EUR 320.45M 12.65M 2025-12
Lakefront Biotherapeutics EUR 35.5M 8.91M 2026-03
Novartis USD 3.24B 101M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
United Therapeutics USD 156.6M 34M 2026-03